Digital Edition: NICE backs life-extending treatment for advanced bladder cancer
NHS patients with advanced urothelial cancer are to be offered a new combination treatment, which trials suggest has survival rates almost twice as long compared to standard treatments.
Welcome! To continue reading either:
Access your account
Log in to your account to access your content on Nursing Times.
Get unlimited access
Subscribe today to access over 6,000 peer-reviewed clinical articles, exclusive learning units, step-by-step procedures, the AI-powered Ask Nursing Times tool, the latest news, expert analysis, and the full NT Archive dating back to 1905.
Premium subscribers also get exclusive access to Nursing Insights – interactive dashboards covering workforce, patient experience, and public health. Benchmark performance, track trends, and make data-driven decisions to improve care and staff wellbeing. Nursing Insights can be purchased separately.
Register for free
Check if you already have access from your company or university
